Aging is the leading risk factor for cancer, Alzheimer’s, diabetes, and heart disease, and Robert A.J. Signer, Ph.D., studies how aging stem cells shape pre-cancer and healthspan. As deputy director of the Sanford Stem Cell Discovery Center, Signer focuses on rare blood-forming stem cells that self-renew, generate all blood and immune cells, and normally sustain more than 35 trillion blood cells, including about 2 million new red blood cells every second. His group finds that these “Zen” stem cells slow protein production to limit damaging “trash,” but aging stresses overwhelm these defenses. Stress response programs such as HSF1 then help both healthy and mutant stem cells, fueling clonal hematopoiesis, a common, untreated pre-cancerous condition linked to cardiovascular disease, inflammation, cancer, and increased mortality. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 41253]

How can Tai Chi be medicine? Sunny Pak, MD, MPH, shares simple movements that steady the mind, strengthen the body, and enhance qi flow. Series: "UCSF Honoring Origins of Mindfulness Series" [Health and Medicine] [Show ID: 41317]

Why did Grandma ask you to drink that soup? Herbalist Yvonne Lau invites you to uncover the hidden secrets and timeless wisdom of Chinese herbs. Series: "UCSF Honoring Origins of Mindfulness Series" [Health and Medicine] [Show ID: 41316]

Families with disabled students often face extra out-of-pocket costs—costs they wouldn’t have if their child weren’t disabled—to secure the same education other students receive for free, yet tax relief for those expenses is limited and unclear. Garret Hoff, J.D., argues that Internal Revenue Code Section 213 and its interpretations reflect a time when disabled people were not viewed as worth public money to educate, leaving families with arbitrary distinctions under the medical expense deduction. Hoff recommends the IRS revise Treasury Regulation 1.213-1(e)(1)(v)(a) to recognize a broader reading of Section 213, and he urges Congress to amend Section 529A, created by the ABLE Act, to lift contribution limits and make contributions tax deductible so families can fund qualified disability expenses through ABLE accounts. Hoff adds that lasting access and justice require cultural change, not only tax revisions. Series: "Autism Tree Project Annual Neuroscience Conference" [Public Affairs] [Health and Medicine] [Show ID: 41178]

How did Chinese herbs take root in America? Join herbalist Yvonne Lau as she explores the resilience and healing wisdom carried across oceans and generations. Series: "UCSF Honoring Origins of Mindfulness Series" [Health and Medicine] [Show ID: 41315]

Balancing caregiving and career, Elizabeth Jalazo, M.D. traces how her daughter Evelyn’s early feeding challenges and later diagnosis of Angelman syndrome reshape her priorities and professional path. Jalazo describes barriers many families face in rare-disease diagnosis, including a “wait and see” approach, specialist access, and insurance denials, and she emphasizes the value of answers for community, care planning, and research access. At UNC Chapel Hill, Jalazo works as a pediatric geneticist and clinical trialist studying interventional therapies for neurodevelopmental and lysosomal storage disorders, and she serves as chief medical officer of the Angelman Syndrome Foundation. She also leads work on Early Check, an opt-in newborn sequencing program in North Carolina, and shares practical lessons about protecting sleep, building support, and saying no while holding space for hope and joy Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Show ID: 41173]

How can five flavors work in harmony? Chef Martin Yan, MS, takes us on a journey to explore how Eastern and Western traditions unite in a simple steamed fish dish. Series: "UCSF Honoring Origins of Mindfulness Series" [Health and Medicine] [Show ID: 41314]

Stem cell science is reshaping treatment for complex disorders of the brain and spinal cord. Researchers develop cell based therapies to replace lost dopaminergic neurons in Parkinson’s disease, fill gaps across spinal cord injuries, and calm seizure networks in refractory epilepsy by restoring the balance of inhibition and excitation. Teams test immune cell therapies against Epstein Barr virus infected B cells in multiple sclerosis and collaborate to move treatments across the blood brain barrier to reach diseased cells. Clinicians combine imaging in the operating room, surgical tools, and research on biological age and the pace of aging to understand disease and guide treatment. Patient advocates describe challenges and hopes for better options, and contemporary art reflects on perception in digital and physical worlds. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40992]

How do you navigate a nonlinear, “squiggly line” career in science and public health? Dr. Katelyn Jetelina, an epidemiologist and scientific communicator, explores challenges of science communication within academia—from cultural resistance to misaligned incentives—and why so much vital research never reaches the public. Joined by Dr. John Schwartzberg, Professor Emeritus, School of Public Health, they discuss the growing opportunities for scientists both within and beyond academia, and what needs to change to better support public impact across all career paths. Series: "UC Berkeley Graduate Lectures" [Health and Medicine] [Science] [Education] [Show ID: 41067]

Exercise is medicine, however, is there an optimal time to take that medicine? Satchidananda Panda, Ph.D., Salk Institute, discusses the benefits and hazards of exercising, depending on the time of day. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 41209]